Johnson & Johnson Innovative Medicine in den Nachrichten
Entwicklung innovativer medizinischer Behandlungen
Tamtam hat 20 aktuelle Artikel über Johnson & Johnson Innovative Medicine gefunden.
- The most innovative medical devices of 2026
- J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch
- [Interview] Rybrevant expands first-line options in EGFR-mutated lung cancer, but cost limits access in Korea
- Johnson & Johnson and Myeloma Ireland launch the 2026 ‘Miles for Myeloma’ Challenge in Cork
- Lilly vs. J&J: Betting on Breakout Growth or Built-In Stability?
- J&J Faces Multiple Headwinds: Can the Healthcare Giant Sustain Growth?
- María Pobre appointed General Manager, Johnson & Johnson Innovative Medicine Ireland – Commercial Operations
- Shockwave to Claim the Johnson & Johnson Name
- Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector?
- Could New Products Shift Johnson & Johnson (NYSE:JNJ) in S&P 500?
- Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Bayer
- J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?
- People on the Move: Tom Cavanaugh Promoted at Johnson & Johnson as EVP, Worldwide Chairman, Innovative Medicine
- Johnson & Johnson (JNJ) Picks Tom Cavanaugh As Jennifer Taubert Plans 2026 Retirement
- Should Johnson & Johnson’s (JNJ) Leadership Shift in Innovative Medicine Require Action From Investors?
- Johnson & Johnson postQ: Innovative Medicine lifts outlook; MedTech weak
- Should Johnson & Johnson’s (JNJ) Leadership Shift in Innovative Medicine Require Action From Investors?
- Johnson & Johnson names new Innovative Medicine leader
- Johnson & Johnson (JNJ) Picks Tom Cavanaugh As Jennifer Taubert Plans 2026 Retirement
- Johnson & Johnson announces change in senior leadership role
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Johnson & Johnson Innovative Medicine?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden